When considering my professional life, I'm a relative newcomer to JMP. In fact, my JMP and JSL (JMP Scripting Language) experience began the day I became a developer here in the JMP Life Sciences group, about four years ago. In contrast, I've been using SAS since I was an undergraduate student
Author
Recently, I experienced an event that brought me back to my childhood. I was having dinner at my brother's house with my sons. The television was on, and at some point Bob Ross' show "The Joy of Painting" came on the air. If you've never experienced the show, it is
This past June, at the Drug Information Association (DIA) annual meeting, I had the opportunity to present and participate in a panel discussion on innovative approaches to ensure quality and compliance in clinical trials. Not surprisingly, a majority of the discussion focused on sponsor responsibilities for building quality into its
In the spirit of shameless self-promotion full disclosure with the goal of collecting huge royalty checks promoting the efficient review of clinical trials, I’d like to make everyone aware of the forthcoming SAS Press title Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS. Clinical trials are
If you work or have worked within the pharmaceutical industry, then you are likely familiar with MedDRA, the Medical Dictionary for Regulatory Activities. This dictionary makes it possible for drug and device companies to perform analyses of adverse events or medical history. First, MedDRA provides a way to consistently map
“They believed that prediction was just a function of keeping track of things. If you knew enough, you could predict anything. That's been cherished scientific belief since Newton.” “And?” “Chaos theory throws it right out the window.” - Michael Crichton, Jurassic Park I’ve been thinking a lot about chaos lately.
New versions of JMP Clinical and Genomics are available starting today, so I wanted to take the opportunity to give a brief overview of some of the new features you’ll come to enjoy with the new release of JMP Clinical 5.0. Below are seven things to love! 1. Risk-Based Monitoring
Greetings, everyone. Sorry for the extra-long blogging hiatus. I have recently been wandering the desert in a self-imposed social media exile (well, mostly) due to some other writing responsibilities. If you’ve been upset over the lack of posts on JMP Clinical or statistics, let me just say that my absence
We’ve talked about the data. We’ve defined our thresholds for risk. Now it’s time to talk about how you can visualize the safety and quality signals from your ongoing clinical trials. If you want to minimize the impact of quality issues to the data or quickly address any safety concerns
Halloween is here. It’s a time when the weather gets colder and the leaves fall from the trees. A time when kids dress up in fun costumes and go trick-or-treating. A time when we start thinking about how to spend the holidays with our family and friends. And if you’re like me,